Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initial Enteral Feeding Strategies in Acute Severe Stroke (OPENS)
NCT02982668Terminated
- Sponsor
- Xijing Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metoclopramide and mosapride in stroke and dysphagia (3 arms), sponsored by Xijing Hospital. Primary endpoint: Proportion of patients with death or major disability (modified Rankin scale score ≥3) at 3 months. Started Jan 2017; status: terminated.
02
Drugs
metoclopramidemosapride
03
Conditions
strokedysphagia
Beyond the preview
Go deeper on NCT02982668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02982668.